LNAI — Lunai Bioworks Inc.

Healthcare • Biotechnology

$1.03
0.03 (—%)

A company rebranding from Renovaro, focusing on AI-powered therapeutics and biodefense, with “Neurotoxicity Intelligence Technology” in development.

Company

Ticker
LNAI
Exchange
Sector
Healthcare
Industry
Biotechnology
Country
US
CEO
David Weinstein
Employees
29
Website
www.renovarogroup.com

Price

Showing 1Y history. Source: FMP “historical price full”.

Prev Close
$1.00
Day High
$1.07
Day Low
$1.00
52w High
$21.00
52w Low
$0.90
Volume
64,355
Avg Volume
Beta
0.389

Key Metrics

Market Cap
18.3M
P/E
P/B
P/S
EV/EBITDA
ROE
Net Margin
Div Yield
FCF/Share

* TTM/most recent where available